Enhanced, Automated & Integrated Analytical Control Strategy & Execution Process for Autologous Cell Therapies
Time: 3:00 pm
day: Day 2 - Afternoon
Details:
- Illustrate how a fully integrated analytical control strategy supports consistency and compliance from development through to commercialization
- Share case studies that demonstrate how proportioning allocations for variation and bias improves control over critical assay elements
- Highlight methods to track and manage analytical variability effectively across development, tech transfer, and commercial operations
